McGuire, D. K., Inzucchi, S. E., Johansen, O. E., Rosenstock, J., George, J. T., & Marx, N. (2021). Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits. J Pharm Policy Pract.
Chicago Style CitationMcGuire, Darren K., Silvio E. Inzucchi, Odd Erik Johansen, Julio Rosenstock, Jyothis T. George, and Nikolaus Marx. "Differences in Glycemic Control between the Treatment Arms in Cardiovascular Outcome Trials of Type 2 Diabetes Medications Do Not Explain Cardiovascular Benefits." J Pharm Policy Pract 2021.
MLA CitationMcGuire, Darren K., et al. "Differences in Glycemic Control between the Treatment Arms in Cardiovascular Outcome Trials of Type 2 Diabetes Medications Do Not Explain Cardiovascular Benefits." J Pharm Policy Pract 2021.